Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Case Reports|January 19, 2026
Gilteritinib in an Isolated CNS Recurrence of FLT3-ITD Positive AMLLina Susana Silva-Bermudez, Alexander Streuer, Foteini Christodoulou, et al.
Leukemia Research|May 17, 2025
Inter-modality variance of blast quantification in patients with myelodysplastic neoplasms (MDS) and its impact on risk stratification and overall survivalLaurenz Steiner, Navkirandeep Kaur, Johann-Christoph Jann, et al.
International Journal of Molecular Sciences|January 21, 2023
In Silico Pan-Cancer Analysis Reveals Prognostic Role of the Erythroferrone (ERFE) Gene in Human MalignanciesQingyu Xu, Eva Altrock, Nanni Schmitt, et al.
Leukemia & Lymphoma|July 30, 2020
RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death eventsJohann-Christoph Jann, Alexander Streuer, Anna Hecht, et al.
JCO Clinical Cancer Informatics|December 23, 2025
Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical DataJonathan Bobak, Philipp Spohr, Sarah Richter, et al.
NPJ Precision Oncology|November 7, 2025
Targeting tumoral heterogeneity in lung cancer: a novel, CT-texture-guided targeted biopsy approach with exome sequencingAlexander Hertel, Alexander Streuer, Steffen Diehl, et al.
Cell Communication and Signaling : CCS|April 4, 2025
Machine learning-based in-silico analysis identifies signatures of lysyl oxidases for prognostic and therapeutic response prediction in cancerQingyu Xu, Ling Ma, Alexander Streuer, et al.
Nature Communications|October 26, 2021
Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivoJohann-Christoph Jann, Maximilian Mossner, Vladimir Riabov, et al.
Haematologica|October 15, 2020
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutationsJohanna Flach, Johann-Christoph Jann, Antje Knaflic, et al.
Annals of Hematology|February 27, 2024
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic NeoplasmsAlexander Streuer, Johann-Christoph Jann, Tobias Boch, et al.
Pageof 2